Mutation of the critical amino acids that govern SLPI anti-protease activity has been implemented, and results have been interpreted as losing the ability to inhibit serine protease, which could not affect the beneficial effect of SLPI, particularly for anti-HIV infection and anti-inflammation [4,19]. The gene discussed is SLPI; the disease is HIV infectious disease.